NUVL
NASDAQ HealthcareNuvalent, Inc. - Class A Common Stock
Biotechnology
📊 Market Data
| Price | $98.00 |
|---|---|
| Volume | 581,508 |
| Market Cap | 7.70B |
| Beta | 1.320 |
| RSI (14-Day) | 44.3 |
| 200-Day MA | $90.79 |
| 50-Day MA | $102.95 |
| 52-Week High | $113.02 |
| 52-Week Low | $55.53 |
| Forward P/E | -24.50 |
| Price / Book | 6.14 |
🎯 Investment Strategy Scores
How NUVL scores across each investment strategy. Higher is better for that strategy's goals.
💰 Dividend Daddy
17/100
High dividend yield + low volatility
🚀 Moon Shot
63/100
High growth potential (high beta + oversold)
🔪 Falling Knife
32/100
Contrarian plays (oversold + below moving average)
🎈 Over-Hyped
62/100
Overbought stocks (potential short candidates)
🐋 Institutional Whale
69/100
Large-cap, institutional-quality stocks
Find NUVL in your text
Paste any text on the homepage — the tool will extract NUVL and other hidden tickers.
Disclaimer: This data is for educational and entertainment purposes only and does not constitute financial advice. Market data may be delayed. Always do your own research before making investment decisions.